Showing 1 posts of 1 posts found.
Novartis has revealed that it has jettisoned two of its clinical stage oncology products along with exclusive global development and …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO